Our Mission
Our mission is to accelerate the potential treatments and cures from our research labs to our healthcare system and make them available for all patients.
Patricia Silverstein sister is the catalyst on her relentless mission finding a cure for diabetes. As she moved to New York in 2018, her younger sister Laura became very ill due to diabetes complications, she developed retinopathy, a disease that affects the eyes and causes blindness, neuropathy. a condition that affects the nerves in legs and feet creating ulcers that could lead to fatal diagnosis as amputations, and lastly and worst of all, she had developed kidney disease also called diabetic nephropathy, and both of her kidneys were rapidly decreasing its function.
At that moment Patricia and Roger went on the search to the best doctors on diabetes in the country, and finally met Dr. Camillo Ricordi and the Diabetes Research Institute, who proposed an innovative treatment with MSC stem cell therapy to regenerate kidney tissue and improve her diabetes complications. Roger and Patricia have been supporting financially the DRI since then and became loyal advocates to diabetes cure and prevention shared mission.
Our Goals
Diabetes Research Institute
Our goal is to provide funding to the most important clinical trial active now at the Diabetes Research Institute, who could be the Biological Cure for Diabetes.
Beta Cell Islet Transplantation. Immunomodulation and Immune Tolerance Induction: to prevent transplant rejection without the requirement for life-long recipient immunosuppression. The proposed strategy utilizes a combination of immunomodulatory cells with the local delivery at the transplant site of tolerogenic molecules, using a novel biologic drug delivery system that was initially developed in Europe for cancer treatment, and that is now ready to be tested to eliminate toxic anti-rejection drugs following transplantation.
National Jewish Health Organization
Our funding will support their research and infrastructures. Their high-complexity, CLIA-certified Bioanalytical and Central Laboratory has decades of experience providing and developing immunology, complement, infectious disease and molecular genomic tests. Focused on improving research sustainability, invigorating research outreach, leveraging research assets, and catalyzing product development.
